Morgan Stanley’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33.8M | Sell |
3,584,155
-264,912
| -7% | -$2.91M | ﹤0.01% | 2487 |
|
|
2025
Q4 | $47.8M | Buy |
3,849,067
+24,404
| +0.6% | +$324K | ﹤0.01% | 2120 |
|
|
2025
Q3 | $54.8M | Sell |
3,824,663
-109,347
| -3% | -$1.5M | ﹤0.01% | 1934 |
|
|
2025
Q2 | $48.3M | Sell |
3,934,010
-876,770
| -18% | -$12.7M | ﹤0.01% | 1967 |
|
|
2025
Q1 | $106M | Sell |
4,810,780
-510,463
| -10% | -$12M | 0.01% | 1211 |
|
|
2024
Q4 | $121M | Buy |
5,321,243
+64,887
| +1% | +$1.42M | 0.01% | 1125 |
|
|
2024
Q3 | $95.5M | Sell |
5,256,356
-242,171
| -4% | -$5.61M | 0.01% | 1276 |
|
|
2024
Q2 | $160M | Buy |
5,498,527
+583,984
| +12% | +$17.3M | 0.01% | 901 |
|
|
2024
Q1 | $174M | Sell |
4,914,543
-5,626,851
| -53% | -$225M | 0.01% | 868 |
|
|
2023
Q4 | $459M | Buy |
10,541,394
+4,592,752
| +77% | +$181M | 0.02% | 710 |
|
|
2023
Q3 | $227M | Sell |
5,948,642
-307,361
| -5% | -$12.9M | 0.02% | 643 |
|
|
2023
Q2 | $257M | Sell |
6,256,003
-317,007
| -5% | -$15.3M | 0.03% | 619 |
|
|
2023
Q1 | $377M | Buy |
6,573,010
+276,245
| +4% | +$15.6M | 0.04% | 448 |
|
|
2022
Q4 | $353M | Buy |
6,296,765
+5,372,602
| +581% | +$273M | 0.04% | 460 |
|
|
2022
Q3 | $39.1M | Buy |
924,163
+40,328
| +5% | +$2.07M | 0.01% | 1515 |
|
|
2022
Q2 | $47.8M | Buy |
883,835
+161,612
| +22% | +$9.71M | 0.01% | 1401 |
|
|
2022
Q1 | $46.4M | Buy |
722,223
+64,315
| +10% | +$4.23M | 0.01% | 1351 |
|
|
2021
Q4 | $44.1M | Sell |
657,908
-75,960
| -10% | -$5.14M | 0.01% | 1435 |
|
|
2021
Q3 | $50.3M | Buy |
733,868
+203,824
| +38% | +$14.4M | 0.01% | 1289 |
|
|
2021
Q2 | $36.2M | Buy |
530,044
+73,317
| +16% | +$5.18M | ﹤0.01% | 1576 |
|
|
2021
Q1 | $31.6M | Sell |
456,727
-18,102
| -4% | -$1.23M | ﹤0.01% | 1526 |
|
|
2020
Q4 | $30.8M | Buy |
474,829
+79,336
| +20% | +$4.27M | ﹤0.01% | 1450 |
|
|
2020
Q3 | $18.7M | Buy |
395,493
+12,060
| +3% | +$574K | ﹤0.01% | 1537 |
|
|
2020
Q2 | $18M | Buy |
383,433
+6,652
| +2% | +$327K | ﹤0.01% | 1490 |
|
|
2020
Q1 | $16.8M | Buy |
376,781
+252,381
| +203% | +$13.2M | ﹤0.01% | 1401 |
|
|
2019
Q4 | $7.25M | Buy |
124,400
+20,698
| +20% | +$1.23M | ﹤0.01% | 2779 |
|
|
2019
Q3 | $6.23M | Buy |
103,702
+76,400
| +280% | +$4.55M | ﹤0.01% | 2636 |
|
|
2019
Q2 | $1.52M | Sell |
27,302
-4,644
| -15% | -$239K | ﹤0.01% | 3981 |
|
|
2019
Q1 | $1.78M | Sell |
31,946
-194,831
| -86% | -$9.92M | ﹤0.01% | 3680 |
|
|
2018
Q4 | $10.2M | Buy |
226,777
+132,753
| +141% | +$7.28M | ﹤0.01% | 2104 |
|
|
2018
Q3 | $6.19M | Sell |
94,024
-63,011
| -40% | -$3.92M | ﹤0.01% | 2952 |
|
|
2018
Q2 | $10.1M | Sell |
157,035
-8,742
| -5% | -$541K | ﹤0.01% | 2369 |
|
|
2018
Q1 | $9.17M | Buy |
165,777
+5,123
| +3% | +$269K | ﹤0.01% | 2427 |
|
|
2017
Q4 | $7.69M | Buy |
160,654
+49,866
| +45% | +$2.44M | ﹤0.01% | 2659 |
|
|
2017
Q3 | $5.59M | Buy |
110,788
+31,561
| +40% | +$1.62M | ﹤0.01% | 2852 |
|
|
2017
Q2 | $4.32M | Sell |
79,227
-265,271
| -77% | -$12.7M | ﹤0.01% | 3009 |
|
|
2017
Q1 | $14.5M | Buy |
344,498
+143,826
| +72% | +$6.15M | ﹤0.01% | 1845 |
|
|
2016
Q4 | $8.61M | Buy |
200,672
+21,258
| +12% | +$864K | ﹤0.01% | 2420 |
|
|
2016
Q3 | $7.41M | Buy |
179,414
+141,846
| +378% | +$5.94M | ﹤0.01% | 2287 |
|
|
2016
Q2 | $1.5M | Sell |
37,568
-138,206
| -79% | -$4.97M | ﹤0.01% | 3665 |
|
|
2016
Q1 | $5.92M | Buy |
175,774
+139,682
| +387% | +$4.35M | ﹤0.01% | 2369 |
|
|
2015
Q4 | $1.22M | Buy |
36,092
+7,940
| +28% | +$248K | ﹤0.01% | 3909 |
|
|
2015
Q3 | $838K | Sell |
28,152
-62,385
| -69% | -$1.95M | ﹤0.01% | 4258 |
|
|
2015
Q2 | $2.49M | Buy |
90,537
+38,001
| +72% | +$1.01M | ﹤0.01% | 3419 |
|
|
2015
Q1 | $1.32M | Sell |
52,536
-2,116
| -4% | -$50K | ﹤0.01% | 3919 |
|
|
2014
Q4 | $1.21M | Buy |
54,652
+10,527
| +24% | +$213K | ﹤0.01% | 3992 |
|
|
2014
Q3 | $895K | Sell |
44,125
-10,598
| -19% | -$211K | ﹤0.01% | 4125 |
|
|
2014
Q2 | $1.05M | Sell |
54,723
-10,101
| -16% | -$188K | ﹤0.01% | 4016 |
|
|
2014
Q1 | $1.22M | Buy |
64,824
+41,306
| +176% | +$797K | ﹤0.01% | 3831 |
|
|
2013
Q4 | $459K | Sell |
23,518
-2,322
| -9% | -$42.6K | ﹤0.01% | 4509 |
|
|
2013
Q3 | $425K | Sell |
25,840
-7,403
| -22% | -$119K | ﹤0.01% | 4440 |
|
|
2013
Q2 | $498K | Buy |
+33,243
| New | +$487K | ﹤0.01% | 4261 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Morgan Stanley's IART Position: Q1 2026 in Review
Morgan Stanley reduced its Integra LifeSciences (IART) stake by 6.9% in Q1 2026, selling an estimated $2.91M and leaving 3,584,155 shares worth $33.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2487.
Morgan Stanley first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $459M in Q4 2023. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Morgan Stanley held 3,584,155 shares of Integra LifeSciences worth $33.8M as of Q1 2026.
- Morgan Stanley sold 264,912 Integra LifeSciences shares in Q1 2026, an estimated $2.91M.
- Integra LifeSciences made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2487 holding.
- Morgan Stanley first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Integra LifeSciences position peaked at $459M in Q4 2023.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.